CLASS II Device recall · Reported 4 Apr 2018 · FDA Enforcement Report

ACE Trochanteric Nail System Troch Nail ST 125DG Strl Troch recalled

Zimmer Biomet is recalling ACE Trochanteric Nail System Troch Nail ST 125DG Strl Troch Nail ST 130DG Strl Troch Nail, distributed nationwide in the US. The recall was initiated on 20 Dec 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codes903211125 903211130 903211135
Quantity recalled3454

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1229-2018
FDA event ID
79408
Recalling firm
Zimmer Biomet, Warsaw, IN
Classification
Class II
Status
Terminated
Recall initiated
20 Dec 2017
FDA classified
27 Mar 2018
Reported
4 Apr 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

20 Dec 2017Recall initiated by company
27 Mar 2018Classified by FDA+97 days
4 Apr 2018Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Zimmer Biomet is conducting a medical device recall for the ACE Trochanteric Nail (ATN) system after a Device Performance Review (DPR) failed clinical analysis for survivorship pursuant to the acceptance criteria for the DPR protocol for the ATN system.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

ACE Trochanteric Nail System TROCH NAIL ST 11X180 125DG STRL TROCH NAIL ST 11X180 130DG STRL TROCH NAIL ST 11X180 135DG STRL The Trochanteric Nail System is intended to treat stable and unstable proximal fractures of the femur including pertrochanteric fractures, intertrochanteric fractures, high subtrochanteric fractures and combinations of these fractures. The Trochanteric Long Nail System is additionally indicated to treat pertrochanteric fractures associated with shaft fractures, pathologic fractures in osteoporotic bone of the trochanteric and diaphyseal areas, long subtrochanteric fractures, ipsilateral femoral fractures, proximal or distal nonunions and malunions and revision procedures.

Where it was distributed

USA (nationwide)

Nationwide

Questions about this recall

Why was it recalled?

Zimmer Biomet is conducting a medical device recall for the ACE Trochanteric Nail (ATN) system after a Device Performance Review (DPR) failed clinical analysis for survivorship pursuant to the acceptance criteria for the DPR protocol for the ATN system.

Which lots are affected?

903211125 903211130 903211135

Where was it sold?

USA (nationwide)

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

10 other products · FDA event 79408

This product is part of a recall event; the main page for the event is ACE Trochanteric Nail System Ster Troc Nail 180X11X140 Ster recalled.

More recalls from Zimmer Biomet

All 873

Other Hip & Knee Implants recalls

All 3,097